Literature DB >> 24916895

The ATP synthase inhibitor bedaquiline interferes with small-molecule efflux in Mycobacterium smegmatis.

Ping Lu1, Cristina Villellas2, Anil Koul2, Koen Andries2, Holger Lill1, Dirk Bald1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24916895     DOI: 10.1038/ja.2014.74

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  6 in total

1.  Selective targeting of Mycobacterium smegmatis with trehalose-functionalized nanoparticles.

Authors:  Kalana W Jayawardana; H Surangi N Jayawardena; Samurdhi A Wijesundera; Thareendra De Zoysa; Madanodaya Sundhoro; Mingdi Yan
Journal:  Chem Commun (Camb)       Date:  2015-08-04       Impact factor: 6.222

2.  Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.

Authors:  Diana Machado; David Pires; João Perdigão; Isabel Couto; Isabel Portugal; Marta Martins; Leonard Amaral; Elsa Anes; Miguel Viveiros
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

Review 3.  Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery.

Authors:  Dirk Bald; Cristina Villellas; Ping Lu; Anil Koul
Journal:  mBio       Date:  2017-04-11       Impact factor: 7.867

4.  IMB-XMA0038, a new inhibitor targeting aspartate-semialdehyde dehydrogenase of Mycobacterium tuberculosis.

Authors:  Xiao Wang; Ruifang Yang; Sihan Liu; Yan Guan; Chunling Xiao; Chuanyou Li; Jianzhou Meng; Yu Pang; Yishuang Liu
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

5.  Plasmid to generate Mycobacteria mutants.

Authors:  Qi Deng; Jianzhou Meng; Yan Guan; Yishuang Liu; Chunling Xiao
Journal:  AMB Express       Date:  2018-02-01       Impact factor: 3.298

Review 6.  Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis.

Authors:  Diana Machado; Miriam Girardini; Miguel Viveiros; Marco Pieroni
Journal:  Front Microbiol       Date:  2018-07-03       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.